These tools will no longer be maintained as of December 31, 2024. Archived website can be found here. PubMed4Hh GitHub repository can be found here. Contact NLM Customer Service if you have questions.
95 related articles for article (PubMed ID: 9425406)
1. Nasal administration of retinal antigens maintains immunosuppression of uveoretinitis in cyclosporin-A-treated Lewis rats: future treatment of endogenous posterior uveoretinitis? Kreutzer B; Laliotou B; Cheng YF; Liversidge J; Forrester JV; Dick AD Eye (Lond); 1997; 11 ( Pt 4)():445-52. PubMed ID: 9425406 [TBL] [Abstract][Full Text] [Related]
2. Effects of mycophenolate mofetil on nasal mucosal tolerance induction. Dick AD; Kreutzer B; Laliotou B; Forrester JV Invest Ophthalmol Vis Sci; 1998 Apr; 39(5):835-40. PubMed ID: 9538893 [TBL] [Abstract][Full Text] [Related]
3. Interphotoreceptor retinoid binding protein is a potent tolerogen in Lewis rat: suppression of experimental autoimmune uveoretinitis is retinal antigen specific. Laliotou B; Liversidge J; Forrester JV; Dick AD Br J Ophthalmol; 1997 Jan; 81(1):61-7. PubMed ID: 9135411 [TBL] [Abstract][Full Text] [Related]
4. [The suppression of the experimental autoimmune uveoretinitis with retinal S antigens by intranasal tolerance induction]. Zheng YZ; Yuan LL; Lin JY; Li HQ Zhonghua Yan Ke Za Zhi; 2006 Dec; 42(12):1118-22. PubMed ID: 17415971 [TBL] [Abstract][Full Text] [Related]
5. Immunomodulation of experimental autoimmune uveoretinitis: a model of tolerance induction with retinal antigens. Dick AD; Cheng YF; Liversidge J; Forrester JV Eye (Lond); 1994; 8 ( Pt 1)():52-9. PubMed ID: 8013720 [TBL] [Abstract][Full Text] [Related]
6. Phenotypic analysis of retinal leukocyte infiltration during combined cyclosporin A and nasal antigen administration of retinal antigens: delay and inhibition of macrophage and granulocyte infiltration. Dick AD; Kreutzer B; Laliotou B; Forrester JV Ocul Immunol Inflamm; 1997 Jun; 5(2):129-40. PubMed ID: 9234377 [TBL] [Abstract][Full Text] [Related]
8. Role of retinal pigment epithelium in the development of experimental autoimmune uveitis. Konda BR; Pararajasegaram G; Wu GS; Stanforth D; Rao NA Invest Ophthalmol Vis Sci; 1994 Jan; 35(1):40-7. PubMed ID: 8300362 [TBL] [Abstract][Full Text] [Related]
9. Intranasal administration of retinal antigens induces transient T cell activation and apoptosis within drainage lymph nodes but not spleen. Laliotou B; Duncan L; Dick AD J Autoimmun; 1999 May; 12(3):145-55. PubMed ID: 10222024 [TBL] [Abstract][Full Text] [Related]
10. Synergistic effect of rapamycin and cyclosporin A in the treatment of experimental autoimmune uveoretinitis. Martin DF; DeBarge LR; Nussenblatt RB; Chan CC; Roberge FG J Immunol; 1995 Jan; 154(2):922-7. PubMed ID: 7814893 [TBL] [Abstract][Full Text] [Related]
11. Nasal administration of retinal antigens suppresses the inflammatory response in experimental allergic uveoretinitis. A preliminary report of intranasal induction of tolerance with retinal antigens. Dick AD; Cheng YF; McKinnon A; Liversidge J; Forrester JV Br J Ophthalmol; 1993 Mar; 77(3):171-5. PubMed ID: 8457510 [TBL] [Abstract][Full Text] [Related]
12. Inhibition of tumor necrosis factor activity minimizes target organ damage in experimental autoimmune uveoretinitis despite quantitatively normal activated T cell traffic to the retina. Dick AD; McMenamin PG; Körner H; Scallon BJ; Ghrayeb J; Forrester JV; Sedgwick JD Eur J Immunol; 1996 May; 26(5):1018-25. PubMed ID: 8647162 [TBL] [Abstract][Full Text] [Related]
13. Anti-tumor necrosis factor alpha therapy suppresses the induction of experimental autoimmune uveoretinitis in mice by inhibiting antigen priming. Sartani G; Silver PB; Rizzo LV; Chan CC; Wiggert B; Mastorakos G; Caspi RR Invest Ophthalmol Vis Sci; 1996 Oct; 37(11):2211-8. PubMed ID: 8843907 [TBL] [Abstract][Full Text] [Related]
14. Resident and infiltrating immune cells in the uveal tract in the early and late stages of experimental autoimmune uveoretinitis. Butler TL; McMenamin PG Invest Ophthalmol Vis Sci; 1996 Oct; 37(11):2195-210. PubMed ID: 8843906 [TBL] [Abstract][Full Text] [Related]
15. Orally induced bystander suppression in experimental autoimmune uveoretinitis occurs only in the periphery and not in the eye. Wildner G; Thurau SR Eur J Immunol; 1995 May; 25(5):1292-7. PubMed ID: 7774632 [TBL] [Abstract][Full Text] [Related]
16. Suppression of S-antigen-induced experimental autoimmune uveoretinitis in Lewis rats by oral administration with CGS-13080, a thromboxane synthetase inhibitor. Li Q; Lopez JS; Caspi RR; Roberge FG; Nussenblatt RB; Kador PF; Chan CC Exp Eye Res; 1993 Nov; 57(5):601-8. PubMed ID: 8282047 [TBL] [Abstract][Full Text] [Related]
17. Modulating phenotype and cytokine production of leucocytic retinal infiltrate in experimental autoimmune uveoretinitis following intranasal tolerance induction with retinal antigens. Laliotou B; Dick AD Br J Ophthalmol; 1999 Apr; 83(4):478-85. PubMed ID: 10434874 [TBL] [Abstract][Full Text] [Related]
18. Effects of a new immunosuppressive agent, FK506, on experimental autoimmune uveoretinitis in rats. Kawashima H; Fujino Y; Mochizuki M Invest Ophthalmol Vis Sci; 1988 Aug; 29(8):1265-71. PubMed ID: 2458329 [TBL] [Abstract][Full Text] [Related]
19. T cell traffic and the inflammatory response in experimental autoimmune uveoretinitis. Prendergast RA; Iliff CE; Coskuncan NM; Caspi RR; Sartani G; Tarrant TK; Lutty GA; McLeod DS Invest Ophthalmol Vis Sci; 1998 Apr; 39(5):754-62. PubMed ID: 9538882 [TBL] [Abstract][Full Text] [Related]